CYLD and amyotrophic lateral sclerosis: A seminal study from 2020 reported a novel mutation in the catalytic domain of CYLD (Met719Val) in an Australian family affected by amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD) [44].